Moraima Jiménez

655 total citations
10 papers, 93 citations indexed

About

Moraima Jiménez is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Moraima Jiménez has authored 10 papers receiving a total of 93 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pathology and Forensic Medicine and 4 papers in Immunology. Recurrent topics in Moraima Jiménez's work include Lymphoma Diagnosis and Treatment (4 papers), Complement system in diseases (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Moraima Jiménez is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), Complement system in diseases (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Moraima Jiménez collaborates with scholars based in Spain and Palestinian Territory. Moraima Jiménez's co-authors include Francesc Bosch, Pau Abrisqueta, Sabela Bobillo, Ana Marín‐Niebla, David Valcárcel, Eva Catalá, Guillermo Villacampa, Cecilia Carpio, Cándido Díaz‐Lagares and Ángela Vidal‐Jordana and has published in prestigious journals such as Blood, Clinical Microbiology and Infection and Transfusion.

In The Last Decade

Moraima Jiménez

9 papers receiving 92 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moraima Jiménez Spain 4 41 28 25 23 18 10 93
Alejandro Luna Spain 7 36 0.9× 21 0.8× 10 0.4× 16 0.7× 6 0.3× 15 82
Audrey M. Sigmund United States 6 45 1.1× 46 1.6× 32 1.3× 36 1.6× 9 0.5× 22 116
Arina Lazareva United Kingdom 5 52 1.3× 55 2.0× 5 0.2× 9 0.4× 7 0.4× 10 108
Jan‐Michel Heger Germany 6 56 1.4× 15 0.5× 31 1.2× 7 0.3× 4 0.2× 23 82
H Schouten Netherlands 5 53 1.3× 22 0.8× 38 1.5× 23 1.0× 4 0.2× 6 81
John C. Molina United States 7 145 3.5× 33 1.2× 10 0.4× 9 0.4× 28 1.6× 21 174
Emily C. Ayers United States 5 35 0.9× 12 0.4× 33 1.3× 17 0.7× 3 0.2× 19 69
Agathe Debliquis France 6 11 0.3× 23 0.8× 27 1.1× 35 1.5× 17 92
M.C. Rousselet France 7 14 0.3× 13 0.5× 16 0.6× 14 0.6× 9 0.5× 23 116
Sophia Bylsma United States 3 98 2.4× 37 1.3× 3 0.1× 8 0.3× 11 0.6× 5 118

Countries citing papers authored by Moraima Jiménez

Since Specialization
Citations

This map shows the geographic impact of Moraima Jiménez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moraima Jiménez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moraima Jiménez more than expected).

Fields of papers citing papers by Moraima Jiménez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moraima Jiménez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moraima Jiménez. The network helps show where Moraima Jiménez may publish in the future.

Co-authorship network of co-authors of Moraima Jiménez

This figure shows the co-authorship network connecting the top 25 collaborators of Moraima Jiménez. A scholar is included among the top collaborators of Moraima Jiménez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moraima Jiménez. Moraima Jiménez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Navarro, Vı́ctor, Moraima Jiménez, Marc Bosch, et al.. (2025). Impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders. Blood Advances. 9(16). 4180–4189. 1 indexed citations
2.
Navarro, Vı́ctor, Gloria Iacoboni, Juan‐Manuel Sancho, et al.. (2024). Rituximab maintenance after bendamustine-based treatment for follicular lymphoma and mantle cell lymphoma may exert a negative influence on SARS-CoV-2 infection outcomes. Haematologica. 110(1). 173–178. 1 indexed citations
3.
Jiménez, Moraima, Alba Cabirta, Isabel Ruíz-Camps, et al.. (2023). Impact of COVID‐19 infection on bispecific antibodies treatment in patients diagnosed with B‐cell lymphoproliferative disorders. Hematological Oncology. 41(S2). 607–609. 1 indexed citations
4.
Andrés, Cristina, Moraima Jiménez, María Piñana, et al.. (2022). Emergence of Delta and Omicron variants carrying resistance-associated mutations in immunocompromised patients undergoing sotrovimab treatment with long-term viral excretion. Clinical Microbiology and Infection. 29(2). 240–246. 15 indexed citations
5.
6.
Grau‐López, Laia, Juan‐Manuel Sancho, Eva González‐Barca, et al.. (2022). Impact of Coronavirus (COVID-19) Pandemic on Maintenance Therapy for Follicular Lymphoma (FL) and Mantle Cell Lymphoma (MCL). Blood. 140(Supplement 1). 9350–9352. 1 indexed citations
7.
Iacoboni, Gloria, Marc Simó, Guillermo Villacampa, et al.. (2021). Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy. Annals of Hematology. 100(9). 2303–2310. 41 indexed citations
8.
Jiménez, Moraima, Sabela Bobillo, Alba Cabirta, et al.. (2020). Real-World Data with the Use of Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura (aTTP). Blood. 136(Supplement 1). 14–16. 2 indexed citations
9.
Cabirta, Alba, Macarena Izuzquiza, Isabel Ruíz-Camps, et al.. (2020). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Hematologic Patients: Experience at the Hospital Attending More Patients in Spain. Blood. 136(Supplement 1). 30–31.
10.
Batlle, Montserrat, Lourdes Vázquez, C. Solano, et al.. (2014). Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation. Haematologica. 99(10). 1632–1637. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alejandro Luna Breakdown of academic impact, for papers by Audrey M. Sigmund Breakdown of academic impact, for papers by Arina Lazareva Breakdown of academic impact, for papers by Jan‐Michel Heger Breakdown of academic impact, for papers by H Schouten Breakdown of academic impact, for papers by John C. Molina Breakdown of academic impact, for papers by Emily C. Ayers Breakdown of academic impact, for papers by Agathe Debliquis Breakdown of academic impact, for papers by M.C. Rousselet Breakdown of academic impact, for papers by Sophia Bylsma
Rankless by CCL
2026